id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-E-2225-0001,FDA,FDA-2022-E-2225,Patent Extension Application from Novartis AG,Other,Application,2022-09-14T04:00:00Z,2022,9,2022-09-14T04:00:00Z,,2022-09-14T15:29:06Z,,0,0,09000064852f7f99
FDA-2022-E-2225-0002,FDA,FDA-2022-E-2225,Cover Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2022-09-14T04:00:00Z,2022,9,2022-09-14T04:00:00Z,,2022-09-14T15:29:27Z,,0,0,09000064852f7f9c